Sigma Pharmaceuticals (SIP) posted a FY12 net profit of $49.2 million
Sigma Pharmaceuticals Limited manufactures, wholesale and distributes prescription, over-the-counter and generic pharmaceutical products. The Company also owns a number of pharmacy banner brands in Australia.
Small Cap Sigma Pharmaceuticals posted a FY12 net profit of $49.2 million, a massive turnaround from the $235.4 million loss in the prior corresponding year
The rise in profit came despite revenue falling 2.1% for the year to $2.9 billion.
The company said that it will pay a final dividend of 2 cents a share and also a special dividend of 1.5 cents, both fully franked.